Gemma Frisius Fund
Venture Capital
Active
Leuven, Belgium
33
7M
25
3
0.24
4
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in Belgium. The leading representative office of defined VC is situated in the Leuven.
Opposing the other organizations, this Gemma Frisius Fund works on 9 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2018. Speaking about the real fund results, this VC is 5 percentage points less often commits exit comparing to other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund.
We can highlight the next thriving fund investment areas, such as Information Technology, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Aristo Music Technology, TROD Medical, Cartagenia.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Gemma Frisius Fund, startups are often financed by Limburgse Reconversie Maatschappij, Vesalius Biocapital Partners, Quest for Growth. The meaningful sponsors for the fund in investment in the same round are PMV, Limburgse Reconversie Maatschappij, University of Leuven. In the next rounds fund is usually obtained by Flanders Innovation and Entrepreneurship (VLAIO), SmartFin Capital, PMV.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 33
- Lead investments
- 3
- Exits
- 4
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (14)
- Health Care (6)
- Therapeutics (5)
- Medical (5)
- Manufacturing (5) Show 32 more
- Investments by region
-
- Belgium (27)
- France (1)
- United Kingdom (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 38K
- Group Appearance index
- 0.97
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Porphyrio | 17 Jul 2014 | Software, Computer, Innovation Management | Early Stage Venture | 1M | Flemish Brabant, Leuven, Belgium |
Protealis | 23 Jan 2024 | Early Stage Venture | 25M |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.